Immunotherapy and Targeted Therapies in the Treatment of Non-small Cell Lung Cancer Table 1 : Key clinical studies in targeted approaches in non-small cell lung cancer

@inproceedings{NguyenNgoc2017ImmunotherapyAT,
  title={Immunotherapy and Targeted Therapies in the Treatment of Non-small Cell Lung Cancer Table 1 : Key clinical studies in targeted approaches in non-small cell lung cancer},
  author={Tu Nguyen-Ngoc and Martin Reck and Daniel S-W Tan and Solange Peters},
  year={2017}
}
I n the last decade, the emergence of targeted therapies has changed the treatment paradigm for non-small cell lung cancer (NSCLC). The growing availability of therapies targeting specific genetic alterations, such as epidermal growth factor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, have led to changes in the guidelines to… CONTINUE READING